of multiple silencing mechanisms (Baniahmad et al., 1992 (Baniahmad et al., , 1995a Damm and Evans, 1993; Lee and Mahdavi, 1993 ; Chromatin disruption and transcriptional activation Qi et al., 1995; Uppaluri and Towle, 1995; Wagner et al. , are both thyroid hormone-dependent processes regu-1995). Transcriptional activation by the TR also involves lated by the heterodimer of thyroid hormone receptor multiple structurally independent domains. A ligandand 9-cis retinoic acid receptor (TR-RXR). In the dependent transactivation domain (AF2) is located at the absence of hormone, TR-RXR binds to nucleosomal carboxy-terminus of the receptor (Zenke et al., 1990 ; DNA, locally disrupts histone-DNA contacts and gener- Barettino et al., 1994) . This domain is required for the ates a DNase I-hypersensitive site. Chromatin-bound release of a putative co-repressor necessary for transcripunliganded TR-RXR silences transcription of the tional silencing (Casanova et al., 1994; , Xenopus TRβA gene within a canonical nucleosomal 1995a). A second transactivation domain includes part of array. On addition of hormone, the receptor directs the hinge region (D region) that links the DNA-binding the extensive further disruption of chromatin structure and ligand-binding domains of the receptor (Lee and over several hundred base pairs of DNA and activates Mahdavi, 1993; Uppaluri and Towle, 1995) . The mechantranscription. We define a domain of the TR protein ism of transcriptional activation by the TR has not yet necessary for directing this extensive hormone-dependbeen defined, although potential co-activators have been ent chromatin disruption. Particular TR-RXR heteroisolated (Halamchmi et al., 1994; Baniahmad et al., 1995b ; dimers containing mutations in this domain are able Le Douarin et al., 1995; Lee et al., 1995a,b; Onate et al. , to bind both hormone and their thyroid hormone Chakravarti et al., 1996) . receptor recognition element (TRE) within chromatin, yet are unable to direct the extensive hormone-dependNucleosome assembly and disruption have an essential ent disruption of chromatin or to activate transcription.
regulatory role in the transcription of many inducible We distinguish the hormone-dependent disruption of genes in yeast and metazoans (Zaret and Yamamoto, 1984 ; chromatin and transcriptional activation as independ- Almer et al., 1986; Straka and Horz, 1991; Archer et al. , ently regulated events through the mutagenesis of basal 1992; Lee and Archer, 1994; Truss et al., 1995) . In yeast, promoter elements and by altering the position and co-repressors organize repressive chromatin structures number of TREs within the TRβA promoter. Chro- (Roth et al., 1990 (Roth et al., , 1992 Vidal and Gaber, 1991 ; Cooper matin disruption alone on a minichromosome is shown et al., 1994; Wolffe, 1995 Wolffe, , 1996 , whereas co-activators to be insufficient for transcriptional activation of the modify histones and disrupt chromatin structure TRβA gene.
Introduction
of T 3 and transcription is activated .
In this work, we make use of mutagenesis of the The thyroid hormone receptor (TR) regulates gene activity Xenopus thyroid hormone β receptor to determine the through alternately silencing or activating transcription role of the AF2 regulatory domain in hormone binding, dependent on the absence or presence of thyroid hormone association with nucleosomal DNA, transcriptional silenc-(T 3 ) (Evans, 1988; Damm et al., 1989; Glass et al., 1989;  ing, transcriptional activation and hormone-dependent dis- Graupner et al., 1989; Sap et al., 1989; ruption of nucleosomal arrays. We localize a ligand-1990 , 1992 Brent et al., 1993) . Silencing of transcription dependent chromatin disruption function to the AF2 by TR is dependent on the action of structurally related domain containing the C-terminal nine amino acids of the co-repressor molecules N-CoR (Horlein et al., 1995) and receptor (Barettino et al., 1994) . We then establish that SMRT (Chen and Evans, 1995) . These co-repressors bind to the receptor in the absence of T 3 and are released in chromatin disruption is a distinct hormone-regulated event targeted by the TR bound to its recognition element in transition in chromatin structure. We next wished to examine the extent of the disruption process. chromatin. Using this information, we demonstrate that chromatin disruption alone is insufficient for transcrip-
The Xenopus TRβA promoter contains a TRE at 264 bp downstream from the start site of transcription (Shi et al., tional activation of the TRβA gene.
1992; Ranjan et al., 1994; Wong et al., 1995) . In our experiments, we utilize a construct containing 1336 bp upstream and 316 bp downstream of the transcription start
Results
site of the TRβA gene fused to a segment of the bacterial Transcriptional regulation and chromatin chloramphenicol acetyltransferase (CAT) gene (Figure disruption by the Xenopus thyroid hormone 2A). We probed for disruption of a canonical nucleosomal receptor array using a probe containing the TRE ( Figure 2B , probe Microinjection of Xenopus oocyte nuclei with single-II), a probe upstream of the TRE ( Figure 2B , probe I), stranded DNA leads to the assembly of chromatin probes including the CAT gene ( Figure 2C , probe III) and (Almouzni and Wolffe, 1993) . Nucleosome assembly downstream of the CAT gene ( Figure 2C , probe IV) and coupled to complementary strand synthesis using singlea vector probe of pBluescript II sequences ( Figure 2D ). stranded DNA as a template occurs with rapid kinetics and
We find that some disruption of a canonical nucleosomal represses basal transcription of the TRβA gene promoter array is obtained over all DNA sequences in the vicinity . Xenopus oocytes are deficient in TR of the transcription unit, as determined by a more diffuse (Eliceiri and Brown, 1994; Wong and Shi, 1995) , thus the micrococcal nuclease (MNase) cleavage pattern dependent capacity of the receptor to regulate transcription from on the presence of TR and T 3 ( Figure 2B and C, compare the TRβA gene promoter can be followed from the lanes 1-4 and 9-12 with lanes 5-8 and 13-16). A more microinjection of mRNA encoding TRβ and/or the 9-cis regular pattern of MNase is found on the pBluescript retinoic acid α receptor (RXRα) which encode the two vector sequences in the presence or absence of ligandsubunits of the heterodimeric receptor. Increasing masses bound TR ( Figure 2D ). It should be noted that probes I, of a mixture of TRβ and RXRα mRNAs lead to the II, III and IV are close to each other and that the disruption synthesis of more receptors able specifically to bind a of nucleosomal organization in either one of the adjacent thyroid response element (TRE) within the TRβA gene DNA segments might contribute to the appearance of . Basal transcription is very low from disruption over both sequences. This is particularly importtemplates in which chromatin assembly is coupled to ant for longer DNA fragments such as those found in trireplication ( Figure 1A , lane 1). However, expression of and tetra-nucleosomes. These experiments make use of increasing amounts of TR in the presence of T 3 prevents α-amanitin to inhibit transcriptional activation (Figure transcriptional repression caused by chromatin ( Figure 1A , 1B), so that any disruption of chromatin is a primary lanes 2-6). To examine the consequences of transcriptional effect of transcriptional activators and not a secondary activation for chromatin disruption on the Xenopus TRβA effect of transcription itself. We conclude that extensive promoter, we established both conditions for robust ligandalterations in chromatin organization occur on the TRβA inducible transcription in the presence of TR-RXR ( Figure  promoter in the presence of TR-RXR and T 3 . Future 1B, lanes 4 and 5) and conditions where transcription experiments will be necessary to determine the degree was inhibited in the presence of α-amanitin ( Figure 1B , to which these transitions in nucleosomal structure are compare lanes 5 and 6). Quantitation of the small amount precisely targeted. of transcription from the TRβA promoter in the absence of exogenous TR-RXR ( Figure 1B , lane 1) reveals no
The role of TR activation domain mutants in significant activation on addition of T 3 ( Figure 1B , lane hormone binding, association with nucleosomal 2) relative to the internal control. Note that the internal DNA, transcriptional silencing, transcriptional control was not affected by α-amanitin since it derives activation and hormone-dependent chromatin from endogenous mRNA already synthesized in the oocyte. disruption We next made use of a supercoiling assay for circular
We next examined the role of the hinge and C-terminal plasmid DNA molecules to determine the extent of chrotransactivation domains of TR in the various biological matin disruption. This assay is based on the fact that each functions of the TR-RXR protein (Zenke et al., 1990 ; nucleosome constrains a single negative superhelical turn Barettino et al., 1994; Casanova et al., 1994; Uppaluri (Germond et al., 1975; Simpson et al., 1985) . Disruption and Towle, 1995) . We introduced six independent point of nucleosomal architecture can lead to changes in the mutations in the hinge and C-terminal domains and created topology of DNA in the nucleosome even if histones are one deletion mutation of the C-terminal nine amino not displaced from DNA (Norton et al., 1989; Bauer et al., acids of the Xenopus TRβA protein ( Figure 3A ). These 1994). Addition of ligand to chromatin-bound TR induces mutations were selected initially because they had been a change in the topology of DNA in the minichromosome shown earlier to influence T 3 -induced transcriptional containing the TRβA promoter that is equivalent to the activation by mammalian/avian TRs, but had been found loss of six nucleosomes ( Figure 1C , compare lanes 4 and not to influence the T 3 or DNA binding affinity (Barettino 5), i.e. the loss of at least 20% of the nucleosomes of Baniahmad et al., 1995a) . Microinjection of entire minichromosome (25 nucleosomes are estimated to mRNA encoding these different proteins into oocyte be assembled on a plasmid of 4.5 kb). This topological cytoplasm led to equivalent synthesis of the corresponding change is independent of transcriptional activation ( Figure  1C , compare lanes 5 and 6). These results indicate that TRs as detected by immunoblotting ( Figure 3B ). In the presence of the heterodimeric partner RXRα, equivalent following the addition of T 3 the TR is inducing a major (1.2, 3.7, 11.1, 33 .3 and 100 ng/ml, lanes 2-6) and then injected with ssDNA of pTRβA (100 ng/ml, 23 nl/oocyte). The oocytes were incubated at 18°C overnight with T 3 . The transcription was analyzed by primer extension. To make sure that injection of ssDNA is uniform for each group of samples, DNAs were recovered from each group and analyzed by slot-blot hybridization with a probe from the TRβA promoter (from ϩ218 to ϩ314). (B) The transcriptional activation by liganded TR-RXR can be inhibited by α-amanitin. Groups of 20 oocytes were injected with ssDNA (100 ng/ml, 23 nl/oocyte) and TR-RXR mRNAs (100 ng/ml, 27 nl/oocyte) and treated with or without hormone as indicated. α-Amanitin was coinjected with ssDNA at a concentration of 10 mg/ml. The transcription was analyzed by primer extension using CAT primer, and the internal control is the primer extension product from an unknown endogenous mRNA as described . (C) The DNA topology assay indicates that liganded TR-RXR also induces extensive chromatin disruption and that this chromatin disruption is not the by-product of processive transcription. The injections were the same as in (B). The DNA was purified from each group and the topological status of the DNA was analyzed using chloroquine agarose gel as described in Materials and methods. The top band in each lane represents the nicked form of plasmid.
DNA-binding activity was recovered ( Figure 3C , and data activation by wild-type TRβ has been correlated with chromatin disruption on the Xenopus TRβA promoter used not shown).
We next examined the capacity of these same mutations in these experiments . We wished to determine which domains of Xenopus TR were required to regulate transcription in a chromatin environment. Using a template that is assembled into a repressive chromatin for the hormone-dependent disruption of chromatin. We find that every TR mutant that activates transcription within structure during replication, we find that deletion of the C-terminal nine amino acids of Xenopus TRβ prevents chromatin also directs the disruption of the canonical nucleosomal array including the TRβA promoter (Figure the activation of transcription in chromatin ( Figure 4A , TRm1, lanes 5 and 6). Likewise, the point mutants TRm4
4B, lanes 9-16). In contrast, TR mutants that do not activate transcription within chromatin do not disrupt the and TRm6 fail to activate transcription within chromatin ( Figure 4A , lanes 7-10). The other mutant TRs all retain canonical nucleosomal array ( Figure 4B , lanes 3-8).
Analysis of the nucleosome disruption process using the the capacity to fully regulate transcription. Transcriptional (A) The diagram shows the structure of the construct and the locations of the probes used for hybridization. Probe I is a 108 bp PstI-RsaI fragment (from -255 to -147); probe II is a 96 bp fragment generated by PCR which covered the TRE site; probe III is a 268 bp CAT gene sequence from BglII (ϩ306) to EcoRI (ϩ584) and probe IV is a 270 bp fragment of pBluescript KS(ϩ) from EcoRI (ϩ584) to PvuII (ϩ854). (B and C) Hybridizations with probes from different regions of the constructs all show hormone-dependent chromatin disruption. The oocytes were injected with ssDNA (100 ng/ml, 23 nl/oocyte) and TR-RXR mRNAs (100 ng/ml each, 27 nl/oocyte) and treated with or without hormone in the presence of α-amanitin (as in Figure 1 , lane 6) and processed for MNase assay. The amounts of MNase used are zero (lanes 1 and 5), 10 (lanes 2 and 6), 5 (lanes 3 and 7) and 2.5 U (lanes 4 and 8). The same filter was hybridized successively with random-primed labeled probes as indicated. (D) Hybridization with the entire vector DNA sequence (pBluescript II). Conditions were as described in (B) and (C).
topological assay ( Figure 4C ) reveals that for the TR . The capacity of the mutant receptors to silence this basal transcription reflects their interaction mutants that fail to activate transcription, the topology of the template is retained (lanes 2-4), whereas those that with both the TRE in the absence of rapid chromatin assembly and their interference with the function of the do activate transcription lose topological constraint equivalent to six nucleosomes ( Figure 4C , lanes 5-8). Thus the basal transcription machinery. Expression of all the mutant proteins in the absence of T 3 leads to the silencing of transactivation domain containing the C-terminal nine amino acids of Xenopus TRβ is required for the activation basal transcription from a microinjected double-stranded template ( Figure 5A , compare lane 1 with lanes 3, 5, 7, of transcription within chromatin, and for the disruption of canonical nucleosomal arrays on the addition of T 3 .
9, 11, 13, 15 and 17). However, in three cases (TRm1, TRm4 and TRm6, Figure 5A , lanes 5-10), silencing is These results establish a strong link between the capacity of the TR to regulate transcription and to disrupt chromatin. not relieved by the addition of ligand. The other point mutations behave like the wild-type TR, fully regulating There are several potential explanations for the failure of the TR mutants (TRm1, TRm4 and TRm6) to activate transcription ( Figure 5A , lanes 11-18). These results are consistent with earlier work demonstrating that certain transcription in a chromatin environment. The mutant receptors might not bind hormone, they might not bind to mutations in the C-terminal transactivation domain can still bind DNA and act as constitutive silencers, but that the TRE in a nucleosomal environment, they might be non-functional in their capacity to interact with the basal addition of hormone does not lead to significant relief of the silencing function (Baniahmad et al., 1995a) . We transcriptional machinery, with the various molecular machines that have been suggested to disrupt chromatin note that TR mutants that can relieve the silencing of transcription on addition of ligand ( Figure 5A , lanes (Yoshinaga et al., 1992; Kingston et al., 1996; Wilson et al., 1996) or with co-activators that modify histones 11-18) can also activate transcription in a chromatin environment ( Figure 4A , lanes 11-18). TR mutants (Ogryzko et al., 1996) . We began to discriminate between these possibilities by examining the capacity of the mutant (TRm1, TRm4 and TRm6) that silence transcription, but that cannot relieve this silencing on addition of ligand receptors to direct transcriptional silencing from a doublestranded template microinjected into the oocyte nucleus.
( Figure 5A , lanes 5-10), do not have the capacity to activate transcription within chromatin ( Figure 4A , lanes Double-stranded DNA is not rapidly assembled into chromatin (Almouzni and Wolffe, 1993) , and in the absence 5-10). Therefore, the transactivation domain containing the C-terminal nine amino acids of Xenopus TRβ is of TR-RXR shows a high level of basal transcription Western blotting analysis of TR mutants expressed in oocytes. mRNAs encoding mutant TRs were synthesized in vitro and injected into groups of oocytes (Materials and methods). After overnight incubation, the groups of oocytes were collected and homogenized, and half an oocyte equivalent was resolved with a 10% SDS-PAGE, blotted to a piece of nitrocellulose filter and vizualized with antibody against recombinant TR using an ECL kit (KPL) (Materials and methods). (C) All TR mutants can form heterodimers with RXR and bind TRE as effectively as wild-type TR. For the gel retardation assay, 1 ml of TR or TR mutant oocyte extract (lanes 4-11) was mixed with 1 ml of RXR oocyte extract and incubated with an end-labeled double-stranded oligonucleotide containing the TRE from the TRβA promoter in 10 μl of binding buffer as described . As controls, uninjected oocyte extract, TR or RXR oocyte extract alone also were used (lanes 1-3). Note that TR alone does not bind to the probe. required both for the relief of silencing and for the ( Figure 5C , arrowheads, compare lanes 8-10 with 11-13). An additional region of DNase I sensitivity is revealed activation of transcription within chromatin dependent on the addition of T 3 .
upstream of the TRE in the presence of hormone (lanes 11-13, indicated by an asterisk). This is consistent with We next examined the capacity of wild-type and mutant TR to associate with radiolabeled T 3 (Eliceiri and Brown, the extensive hormone-dependent disruption of chromatin directed by the wild-type receptor (see Figure 4B ). Some 1994). We find that TRm1 and TRm6 are substantially reduced in their capacity to bind hormone, whereas TRm4 of the sites that are preferentially accessible to DNase I in the upstream region might reflect the association of binds hormone with an efficiency comparable with the wild-type TR ( Figure 5B ). Thus the failure of TRm1 and other specific transcription factors (see Figure 6 later).
Comparison of the wild-type and mutant receptors demonTRm6 to activate transcription in a chromatin environment (Figure 4 ) potentially can be accounted for by a failure strates that they can all associate with chromatin to generate a DNase I-hypersensitive site, albeit with varying to interact efficiently with hormone.
Our next experiments examined the capacity of the efficiency. However, the TRm1 mutation in which the C-terminal nine amino acids of the receptor are deleted mutant and wild-type receptors to associate with nucleosomal DNA in vivo. Earlier work had established that assembles a receptor that only weakly generates any DNase I hypersensitivity ( Figure 5C , lanes 18-21). We TR-RXR would interact with chromatin in the presence or absence of hormone in vivo .
suggest that the failure of the TRm1 mutant receptor to activate transcription in a chromatin environment might The association of wild-type TR-RXR with DNA in a nucleosome leads to a local disruption of histone-DNA be due to a deficiency in the capacity of the receptor to interact with chromatin. Importantly, the TRm4 mutant contacts in the nucleosome . This hormone-independent local disruption of chromatin can receptor retains the capacity to bind both T 3 ( Figure 5B ) and nucleosomal DNA ( Figure 5C ) yet fails to activate be detected as a DNase I-hypersensitive site ( Figure 5C , arrowheads, compare lanes 1-7 with lanes 8-13). On transcription in a chromatin environment ( Figure 4A ) and to disrupt chromatin ( Figure 4B and C). These results addition of hormone, the DNase I hypersensitivity generated by the wild-type receptor becomes more pronounced indicate that mutations in the C-terminal nine amino acids The groups of oocytes were injected with ssDNA of pTRβA (100 ng/ml, 23 nl/oocyte) and with mRNAs encoding RXR and TR or TR mutants (100 ng/ml each, 23 nl/oocyte) and treated with T 3 (50 nM) overnight. Half of the oocytes in each group were used for transcriptional analysis by primer extension and half for chromatin disruption analysis by MNase assay. Note that TRm1, TRm4 and TRm6 failed to activate transcription from the TRβA promoter (compare lanes 6, 8 and 10 with lane 4). The internal control represented the extension product of the endogenous oocyte H4 mRNA using the H4 primer. (B) The mutants impaired in transcriptional activation also failed to disrupt canonical chromatin structure as assayed by MNase. Partial MNase digestions of minichromosomes were carried out with 10 U of MNase in the even lanes and 5 U of MNase in the odd lanes at room temperature for 20 min as described in Materials and methods. The DNAs were purified, resolved with a 1.5% agarose gel, blotted to Nytran Plus membrane and probed with random primer-labeled DNA fragment including the TRE (from ϩ218 to ϩ314). Also indicated on the right are the positions of mono-, di-, tri-, tetra-and penta-nucleosomal DNAs. (C) The DNA topological assay again indicates that the mutants deficient in transcriptional activation are defective in hormone-dependent chromatin disruption. The injection of oocytes was as described above. After overnight treatment with hormone, the groups of oocytes were used for DNA purification and topology assay. The filter is probed with the random primer-labeled probe III (Figure 2A ).
of TR can interfere with transcriptional activation and hormone-dependent chromatin disruption that is also dependent on a defined transactivation domain (Figures 3 chromatin disruption in a highly selective manner. We next sought to establish whether chromatin disruption was and 4). We wished to determine if the association of other sequence-specific DNA-binding proteins necessary for a primary function of the Xenopus thyroid hormone receptor, or a secondary effect dependent on the association transcription from the TRβA promoter was a prerequisite for chromatin disruption. We made use of 5Ј deletion of other sequence-specific DNA-binding proteins with the TRβA promoter.
mutants of the TRβA promoter and the internal location of the TRE to determine the role of the TRE and sequences 5Ј to the TRE in transcriptional activation and chromatin Chromatin disruption is targeted by the thyroid hormone receptor disruption ( Figure 6A ). Sequence-selective hormonedependent initiation of transcription required sequences The Xenopus TR binds to nucleosomal DNA in vitro and in vivo, generating local alterations in nucleosome structure 5Ј to the TRE itself ( Figure 6B , compare lanes 1 and 2 with lanes 5 and 6 and 9-12). Deletion of these sequences detected as DNase I hypersensitivity but without extensive disruption of chromatin in the absence of ligand ( Figure  5Ј to -258 significantly reduces both the efficiency of chromatin disruption ( Figure 6C , compare lanes 1 and 2 5, Wong et al., 1995) . Addition of ligand leads to extensive Figure 4 except that the dsDNA of pTRβA (100 ng/ml, 23 nl/oocyte) was used. (B) The TR mutant defective in hormone-dependent transcriptional activation can still retain high affinity for binding of hormone. The TR and TR mutants, overexpressed in oocytes as described in Figure 3 , were used for filter binding assay using [ 125 I]T 3 as ligand. The result shown represents the mean value of three independent experiments. (C) The mutants defective in hormone-dependent transcription activation and chromatin disruption can bind to the TRE in chromatin as wild-type receptor and induce the formation of DNase I-hypersensitive sites. The groups of oocytes were injected with or without TR-RXR mRNAs (100 ng/ml each, 27 nl/oocyte) and ssDNA of pTRβA (100 ng/ml, 23 nl/oocyte) and treated with or without T 3 as indicated. After overnight incubation, the groups of oocytes were collected and used for the DNase I sensitivity assay. The DNase I concentrations were 80 (lanes 14, 18, 22 and 26), 40 (lanes 5, 8, 11, 15, 19, 23 and 27), 20 (lanes 6, 9, 12, 16, 20, 24 and 28) and 10 U (lanes 7, 10, 13, 17, 21, 25 and 29) . The naked plasmid controls were treated with a 200-fold smaller amount of DNase I. Also indicated are the positions of EcoRI sites and the TRE. The probe used is probe III (Figure 2) . The asterisk represents the position of the increase of DNase I cleavage in response to hormone-bound receptor 5Ј to the TRE (lanes 11-13).
with 5 and 6) and transcriptional activation ( Figure 6B , appears independent of high levels of specific transcriptional activation. Removal of the TRE, together with compare lanes 1 and 2 with 7 and 8). A contributory factor to these changes is the elimination of a second TRE sequences 5Ј including the transcription start site, leads to the loss of both sequence-selective hormone-dependent at -785 relative to the start site of transcription (ϩ1) (Machuca et al., 1995; Wong et al., 1995) . The binding transcriptional activation and chromatin disruption ( Figure  6B and C, lanes 3 and 4). Thus the TRE alone is sufficient of the TR-RXR to this site might contribute some specificity to the DNase I cleavage sites seen in Figure 5C to confer hormone-dependent chromatin disruption in the presence of TR. upstream from the start site of transcription. Further deletion of the region from -258 to ϩ264 has no major Our results further suggest that chromatin disruption per se is not sufficient for transcriptional activation and effect on the efficiency of chromatin disruption ( Figure  6C , compare lanes 7 and 8 with lanes 5 and 6 and 9-12), that while the TR alone is sufficient to target the chromatin disruption process ( Figure 6C , lanes 5 and 6), it is not whereas these sequences are essential for transcription ( Figure 6B , compare lanes 7 and 8 with lanes 5 and 6 sufficient to target the accurate initiation of transcription by RNA polymerase II ( Figure 6B , lanes 5 and 6). and 9-12). Thus the efficiency of chromatin disruption The TRE, initiator and an upstream element are all required for the transcriptional activation of TRβA promoter by liganded TR-RXR. The groups of oocytes were injected with or without TR-RXR mRNAs (50 ng/ml each, 27 nl/oocyte) and ssDNA constructs (100 ng/ml, 23 nl/oocyte) as indicated. After incubation with hormone overnight, the groups of oocytes were collected for RNA purification. The transcription from the constructs was then analyzed by primer extension. (C) The TRE alone is sufficient to target chromatin disruption by liganded TR-RXR. Injection and treatment of the oocytes were performed as above. DNAs were purified from each group of injected oocytes and analyzed for topology changes using chloroquine agarose gel. DNAs were then transferred to the Nytran Plus membrane and probed with random primer-labeled probe III (Figure 2 ).
Chromatin disruption is not sufficient for
these regulatory elements was also required. We also explored the role of the TRE as an enhancer of transcription transcriptional activation Our experiments demonstrate that the TR-RXR in the by examining whether transcriptional stimulation was independent of the distance of the TRE from the promoter presence of T 3 can direct chromatin disruption indicated by the loss of approximately three negative superhelical and how this might influence both chromatin disruption and transcriptional activation. turns from a single TRE ( Figure 6C , lanes 5 and 6). In contrast, the wild-type promoter containing two TREs
The constructs employed in these experiments use a single TRE 1132 bp downstream of the start site of (Ranjan et al., 1994; Machuca et al., 1995; Wong et al., 1995) directs the disruption of approximately six nucleotranscription ( Figure 7A ) or four clustered TREs at this position separated individually by 26 bp. Control gel-shift somes ( Figure 1C , lanes 5 and 6; Figure 6C , lanes 1 and 2). We next examined whether chromatin disruption experiments indicate that this spacing is sufficient for four TR-RXR complexes to bind (data not shown). We also directed by hormone-bound receptor would depend simply on the number of TREs or whether a spatial separation of generated templates with two, three and four TREs separ-ponding to the loss of three negative superhelical turns of topological constraint. In contrast, the separation of TREs over hundreds of base pairs leads to a progressive increase in hormone-dependent chromatin disruption ( Figure 7B , lanes 5-10). This suggests that the chromatin disruption is centered on each TRE and is transmissible in cis for a limited but undefined range. Surprisingly, although both a single and four clustered TREs 1132 bp downstream of the transcription start site disrupt chromatin to equivalent extents ( Figure 7B , compare lanes 1 and 2 with 3 and 4), there are very different consequences for transcriptional activation. A single TRE cannot activate transcription at this position ( Figure 7C, lanes 1-3) , whereas four clustered TREs activate transcription ( Figure 7C , lanes 4-6). Placement of multiple dispersed TREs closer to the start site of transcription activates transcription as efficiently as the four clustered TREs at 1132 bp downstream ( Figure 7C , compare lanes 6, 9, 12 and 15). However, increasing levels of chromatin disruption do not correlate with progressive increases in transcriptional efficiency ( Figure  7C ). We suggest that not only is chromatin disruption regulated independently by the TRE but that a localized region of chromatin disruption itself at this distal site is insufficient for transcriptional activation ( Figure 7B , lanes 1-4; Figure 7C , lanes 1-6).
We next examined the distance-dependent effects of single or multiple TREs from the start site of transcription on both chromatin disruption and transcriptional activation ( Figure 8A ). Single or multiple clustered TREs are able to direct hormone-dependent chromatin disruption to equivalent extents, independently of their position relative to the transcription start site ( Figure 8B ). In contrast, a single TRE is able to direct transcriptional activation 264 and 584 bp downstream from the start site, but not 1132 bp downstream ( Figure 8C , compare lanes 7, 8, 11 and 12 with 15 and 16). These results again suggest that hormonedependent chromatin disruption does not require transcriptional activation and that hormone-dependent chromatin disruption alone at a distal site is insufficient for tran- The major conclusions from this work are: (i) that the TR oocytes were injected with TR-RXR mRNAs (50 ng/ml each, bound to its recognition site within chromatin is sufficient 27 nl/oocyte) and the ssDNA constructs (100 ng/ml, 23 nl/oocytes) and then treated with or without hormone overnight as indicated. The to instigate the disruption of nucleosomal arrays dependent oocytes were then collected for purification of DNA for supercoiling on both a defined transactivation domain and the addition assay. After transfer to Nytran Plus membrane, DNAs were probed of T 3 (Figures 1-6) ; and (ii) that hormone-dependent with random primer-labeled probe III (Figure 2 ). Also shown on the chromatin disruption itself on a mini-chromosome is right are the scans of the corresponding supercoiling assay data by insufficient for transcriptional activation (Figures 6-8 ).
phosphorimaging (Molecular Dynamics). (C) The increasing levels of chromatin disruption do not correlate with increasing levels of
Our results indicate that although chromatin disruption is transcriptional activation. The groups of oocytes were injected without linked tightly to transcriptional activation (Figure 4) , it is (lanes 1, 4, 7, 10 and 13) or with TR-RXR mRNAs of 10 ng/ml possible to separate these two processes in vivo ( Figures   (lanes 2, 5, 8, 11 and 14) or 100 ng/ml (lanes 3, 6, 9, 12 and 15) and 6-8). Although chromatin disruption is an independent the ssDNA constructs as indicated. Each group of oocytes was treated with hormone overnight and then collected for purification of RNA for hormone-regulated function of the thyroid hormone recepprimer extension analysis.
tor, additional activities of the receptor are required for transcriptional activation. ated by distances of 548, 274 and 578 bp, as indicated ( Figure 7A ). We find that one or four clustered TREs at Silencing, relief of silencing, transcriptional activation in chromatin and chromatin disruption the same site 1132 bp downstream of the transcription start site give very similar extents of hormone-dependent by the thyroid hormone receptor Minichromosomes assembled on microinjected doublechromatin disruption ( Figure 7B, lanes 1-4) . Densitometric scanning suggests a disruption, in both instances corresstranded DNA have high levels of basal transcription that 1995a), which demonstrated that deletion of the conserved nine amino acids PLFLEVFED significantly reduces the relief of silencing (TRm1), as does point mutation of this sequence at the glutamic acid residue at position five (TRm4). The point mutation (TRm6) which alters the first proline to serine adds another TR variant deficient in relief of silencing ( Figure 5A ). Importantly, these mutant forms of the TR do not activate transcription within a repressive chromatin environment assembled on a replicating template (Figure 4, lanes 5-11) . For two of these mutants, control experiments indicate that either a deficiency in hormone binding (TRm1 and TRm6) or a deficiency in binding to nucleosomal DNA (TRm1) might interfere with hormone-induced functions of the receptor in chromatin. This failure to bind nucleosomal DNA might account for the relative inefficiency of TRm1 in silencing transcription in chromatin ( Figure 4A , compare lanes 1 and 5). Importantly, one mutant, TRm4, retains the capacity to bind both hormone ( Figure 5B ) and nucleosomal DNA ( Figure 5C ). However, TRm4 remains deficient in disrupting chromatin and in activating transcription (Figure 4 ). Thus the C-terminal transactivation domain previously defined (Zenke et al., 1990; Barettino et al., 1994; Baniahmad et al., 1995a) has an essential novel role both in transcriptional activation within a chromatin environment and in targeting chromatin disruption. The rat TR has been crystallized recently and its structure in the presence of ligand resolved (Wagner et al., 1995) . The C-terminal activation domain forms an amphipathic helix, with the hydrophobic face actually constituting part of the hormone-binding cavity. The potential structural role for the ligand provides an attractive explanation for the allosteric transition in the TR that enables the protein to activate transcription (Wagner et al., 1995) . Whatever contacts that are made by this domain with other proteins, such as co-repressors or co-activators, must control transcription in a chromatin environment. In contrast to the clear role of the C-terminal domain of the TR in gene regulation, the role of the hinge (D) region in and Towle, 1995) is not revealed in our assay system. We TREs in each construct. In TRpm(P) and all of its derivative use microinjection of Xenopus oocytes as an assay system constructs, the TRE was mutated and no longer can bind to TR-RXR . (B) The supercoiling assay indicates that a single (Almouzni and Wolffe, 1993) ; the earlier work indicative TRE or multiple TREs clustered at a single site at different locations of a regulatory role for the D region made use of transfected mediate the chromatin disruption induced by liganded TR-RXR to mammalian cells (Lee and Mahdavi, 1993) or yeast similar extents. The groups of oocytes were injected with TR-RXR (Uppaluri and Towle, 1995) . It is possible that the Xenopus mRNAs (100 ng/ml each, 27 nl/oocyte) and the ssDNA constructs (100 ng/ml, 23 nl/oocytes) and then treated with or without hormone oocyte lacks appropriate co-activators or co-repressors overnight as indicated. The oocytes were then collected for purification present in these other cells, or that chromatin assembly in of DNA for the supercoiling assay. After transfer to Nytran Plus our system introduces constraints not apparent in the membrane, DNAs were probed with random primer-labeled probe III earlier assays. We conclude that microinjection of the Xenopus TRβA the start site, are able to activate the transcription of TRβA promoter by liganded TR-RXR. The groups of oocytes were injected without promoter into Xenopus oocyte nuclei allows confirmation (lanes 1-6) or with TR-RXR mRNAs of 10 ng/ml (lanes 7, 9, 11, 13, of earlier functions attributed to the C-terminal transactiv-15 and 17) or 100 ng/ml (lanes 8, 10, 12, 14, 16 and 18) and the ation domain of the receptor (Barettino et al., 1994;  ssDNA constructs as indicated. Each group of oocytes was treated Baniahmad et al., 1995a; Wagner et al., 1995) together with hormone overnight and then collected for purification of RNA for primer extension analysis.
with the attribution of a new function-the hormonedependent disruption of chromatin. are silenced efficiently upon the expression of the receptor in the absence of T 3 ( Figure 5A ). All of the mutant TR Chromatin disruption instigated by the thyroid hormone receptor proteins used in our experiments silence basal transcription. Some of these mutant TRs will not relieve silencing Chromatin disruption is tightly correlated with the inducible transcription of many genes (Burch and on addition of T 3 ( Figure 5A, lanes 3-11) . The nature of these mutations confirms earlier work (Baniahmad et al., Weintraub, 1983; Zaret and Yamamoto, 1984; Elgin, 1988; Gross and Garrard, 1988) . Genetic experiments in obtained in our experiments does not depend on DNA binding of the transactivator alone, but is also dependent Saccharomyces cerevisiae indicate an essential role for on a ligand-binding transactivation domain (Figure 4 ). histone-DNA contacts in repressing basal transcription Thus we can dissect the process of TRβA gene activation and demonstrate that relief of this repression is a major into three steps: binding of the receptor to chromatin in component of transcriptional activation (Han and the absence of ligand ( Figure 5C ), disruption of chromatin Kruger et al., 1995) .
on addition of ligand (Figures 2 and 4B and C), and For example, disruption of histone-DNA contacts through transcriptional activation (Figures 1, 4 , 5, 7 and 8). reduction in histone gene copy number activates PHO5 transcription independently of an inductive signal (Han Chromatin disruption is insufficient for et al., 1988) . During normal induction of PHO5, the action transcriptional activation of a transcriptional activator PHO4p on an organized
Our results with single versus clustered multiple TREs chromatin structure (Straka and Horz, 1991; Fascher indicate that chromatin disruption is insufficient for comet al., 1993; Svaren et al., 1994 ) is required to disrupt plete transcriptional activation. A single TRE at a distance nucleosomal arrays Almer et al., of 1132 bp from the transcription start site disrupts 1986). Recent evidence suggests that a co-repressor RPD3p chromatin to the same extent as four clustered TREs at that probably functions as a histone deacetylase also the same position (Figures 7 and 8) . Nevertheless, the contributes to PHO5 gene regulation (Vidal and Gaber, single TRE does not activate transcription efficiently, 1991; Taunton et al., 1996; Wolffe, 1996) . In metazoans, whereas the four TREs can. There are two possible experiments using the mouse mammary tumor virus long explanations for these results: (i) that chromatin disruption terminal repeat paradigm have shown that the ligandis an epiphenomenon that is not required for transcriptional bound glucocorticoid receptor disrupts chromatin (Zaret activation, or (ii) that chromatin disruption might be and Yamamoto, 1984) . In this case, the chromatin consists permissive for transcriptional activation from the TRβA of a phased nucleosomal array (Richard-Foy and Hager, promoter but that additional interactions between the TR-1987). Positioned nucleosomes facilitate the association RXR and the transcriptional machinery are necessary to of ligand-bound glucocorticoid receptor (Perlmann and activate transcription. We favor the latter possibility. Wrange, 1988; Pina et al., 1990) . Once bound to chromatin, Chromatin disruption leads to major topological changes the glucocorticoid receptor initiates a process leading to in minichromosomes (Figures 1, 4 , 6, 7 and 8), consistent chromatin disruption and the assembly of a functional with a loss of wrapping of DNA around the histones pre-initiation complex (Archer et al., 1989 (Archer et al., , 1992 Lee (Germond et al., 1975; Bauer et al., 1994) . Although and Archer, 1994) . Thus, for these inducible systems, histone acetylation is associated with targeted co-activators chromatin disruption is linked intimately to transcriptional (Brownell et al., 1996; Wolffe and Pruss, 1996) , including activation. TR differs from these systems in that it binds the p300 protein involved in nuclear receptor signaling to a phased nucleosomal array in vivo in the absence of (Chakravarti et al., 1996; Ogryzko et al., 1996) , it is ligand, but fails to activate transcription (Wong et al., difficult to account for the large topological change 1995). We find that the association of unliganded receptor observed in our experiments through acetylation alone with nucleosomal DNA is sufficient to generate a DNase (Norton et al., 1989; Bauer et al., 1994) . Moreover, histone I-hypersensitive site ( Figure 5C ) indicative of local disrupacetylation alone is insufficient to relieve transcriptional tion of histone-DNA contacts; however, chromatin strucrepression without the removal of histone H1 (Ura et al., ture, as indicated by a defined nucleosomal array or 1997). The removal of histone H1 from chromatin is topological constraint, is not disrupted under these condiassociated with gene activation (Bresnick et al., 1992) . tions (Figures 1C and 2B and C) . Only on the addition of Histone H1 deficiency increases nucleosome mobility ligand does a major topological change ( Figure 1C ) occur, (Pennings et al., 1994; Ura et al., 1995) and thereby coupled to an extensive loss of definition in MNase facilitates transcription (Ura et al., 1995; Varga-Weisz cleavage (Figure 2 ). These results indicate that chromatin et al., 1995) . However, the topological change following remodeling at the TRβA promoter is a two-step phenomfrom the removal of histone H1 is unlikely to be large enon. The first step represents the generation of a DNase (Hamiche et al., 1996) . The most likely explanation for the observed topological change is an unfolding of the I-hypersensitive site dependent on unliganded receptor, nucleosome, reflecting a disruption of core histone interbut hormone-dependent chromatin disruption involves the actions with DNA and with each other. Such changes disruption of nucleosomes flanking the TRE over several might reflect the loss of DNA wrapping observed when hundred base pairs (Figure 2) . The more extensive disrupmononucleosomes are exposed to large excesses of the tion can also be detected by DNase I ( Figure 4C , lanes SWI-SNF general activator complex (Côté et al., 1994; 11-13, indicated by the asterisk). Imbalzano et al., 1994) . These changes clearly can disperse We have shown that the TR alone and its recognition over an extensive region of chromatin ( Figure 2 ) and need element are sufficient to initiate a process of chromatin not be localized to the complete disruption of nucleosomes disruption over an extended segment of DNA sequence immediately adjacent to the TRE. Future experiments will (Figures 2, 4, 6 and 7) . The disruption of chromatin from attempt to define the nature of this chromatin reorganizthe wild-type promoter containing two TREs is equivalent ation and its enzymatic basis. to the loss of the topological constraint found in six nucleosomes (Figures 2 and 4) . Transcription is not
Materials and methods
required for chromatin disruption (Figure 2) , and additional proximal promoter elements are necessary to facilitate
Plasmid constructs
hormone-dependent activation of transcription by the TR pSP64(polyA)-xTRβA and -xRXRα constructs have been described before . All TRβA mutants were generated using a ( Figure 6 ). The hormone-dependent chromatin disruption mixed with an equal concentration of RXRα mRNA to give a final Table I . List of primers used for generating TR mutants a concentration of 100 ng/ml for each and injected into the cytoplasm of the oocyte at a volume of 27.6 nl per oocyte, except in Figure 1 in TRβ1 CAACGGTCGACATGGAAGGGTATATACCC which a series of 3-fold dilutions (from 100 ng/μl up to 81-fold dilution) TRβ2 CATTTGGATCCATGTCTATTTAGAACG of TR-RXR were used to examine the dosage effect of TR-RXR. The TRm1 CTTCGGATCCTAGGGAAACAGTTCAGTGG injected oocytes were incubated at 18°C overnight in MBSH buffer TRm2 GTGCGGATCCTAGTCCGCAAACACTTCCAAGAA (Peng, 1991) with 50 U/ml of ampicillin and streptomycin in the presence TRm4 GTGCGGATCCTAGTCCTCAAACACTTTCA (ϩ) or absence (-) of 50 nM of T3 as indicated. TRm6 GTGCGGATCCTAGTCCTCAAACACTTCCAAGAACAGTGAG TRm5 GTGCGGATCCTAGTCCTCAGGCACTTCCAA Gel retardation assay and Western blotting analysis TRm7 GCAAAAAGAAAGCTCACAGAAGAAAACAGAG The gel retardation assay and Western blotting analysis of TR-RXR TRm8 CTCTGTTTTCTTCTGTGAGCTTTCTTTTTGC expressed in oocytes injected with TR or TR-RXR mRNAs have been TRm9 CTCATAGAAGAAAACCACGAAAAAAGACGGAAA described elsewhere . TRm10 TTTCCGTCTTTTTTCGTGGTTTTCTTCTATGAG Ligand-binding assay a The mutated residues are underlined.
The assay for the binding of T 3 to the receptor and the receptor mutants utilizing [ 125 I]T 3 was performed essentially as described (Eliceiri and Brown, 1994) , except that the Xenopus oocyte-expressed receptors PCR method based on pSP64(polyA)-xTRβA. In brief, TRβm1-TRβm6 were constructed by replacing the AflIII-BamHI fragment of the were used. pSP64(polyA)-xTRβA with the AflIII-BamHI fragments of the PCR products generated with a TRβ1 primer and a corresponding mutant Transcription analysis and DNA analysis Preparation of RNA from injected oocytes and transcription analysis by primer, as listed in Table I . To make TRβm7 and TRβm9, pSP64(polyA)-xTRβA was first amplified with a pair of primers, TRβ1 and TRβm7, primer extension were performed as described . In brief, 20 healthy oocytes for each sample were collected after overnight and another pair of primers, TRβm8 and TRβ2, respectively. Two PCR products were gel purified, mixed and then PCR amplified with TRβ1 incubation, rinsed once with MBSH buffer and homogenized in 200 ml of 0.1 M Tris (pH 8.0) and 20 mM EDTA (pH 8.0). The homogenates and TRβ2 primers. The full-length PCR product was gel purified and digested with SalI and AflIII. The resulting SalI-AflIII fragment was were then divided into two halves, one for RNA purification and another for DNA purification. For RNA purification, 500 ml of RNAzol™ used to replace the corresponding fragment in the wild-type pSP64-(polyA)-xTRβA construct to generate pSP64(polyA)-TRβm7. The reagent together with 50 ml of chloroform were added to each sample. The samples were vortexed vigorously and incubated on ice for 15 min pSP64(polyA)-TRβm9 was generated in the same way as pSP64(polyA)-TRβm7 except that TRβm9 and TRβm10 primers were used. The PCR before centrifugation at top speed in a bench top centrifuge. The clean supernatants (350 ml) were transferred to new tubes and RNAs were fragment in each construct was verified by DNA sequencing.
The pTRβA construct which contains 1.6 kb of TRβA promoter and precipitated with 0.7 volume of isopropanol. After rinsing with 70% ethanol, RNAs were resuspended in DEPC-treated water and prepared 0.3 kb of CAT gene sequence in pBluescript II KS(ϩ) has been described before . The TRp(PstI) construct was generated from for primer extension analysis using the primer I (ATCCTTATAAA-CGGTGAGTAGTGATGTCATCAG) as described . pTRβA by deleting all PstI fragments from the TRβA promoter. TRpm2, TRpm3, TRp4(-TRE) and TRp5(ϩTRE) plasmids were all constructed
The internal control is the primer extension product of the endogenous histone H4 mRNA using primer H4 (GGCTTGGTGATGCCCTGGby PCR based on the TRp(PstI) construct. TRpm1 plasmid containing a 5 bp deletion (GGGGG), which included the transcriptional start site ATGTTATCC).
To recover DNA for either quantifying the amount of injected DNA (underlined) in the initiation region, was generated by site-directed mutagenesis based on the TRp(Pst I) using an Amersham kit as described in different samples or examining the supercoiling status of the DNA, 200 ml of 1% SDS and 50 mM EDTA were immediately added to the by the manufacturer. The TRpm(P) construct has been described before . The plasmids TRpm(P)-1.TRE and TRpm(P)-4.TRE remaining half of the samples. The samples were treated with RNase A (100 mg/ml) at 37°C for 2 h, followed by treatment with proteinase K were generated respectively by inserting one and four TREs (5Ј AGCTTGCAGGTCATTTCAGGACAGCA 3Ј) into the HindIII site of (200 mg/ml) for 2-3 h at 55°C. After addition of 30 μl of 3 M NaOAC, pH 5.4, the samples were phenol/chloroform extracted twice, precipitated the TRpm(P) construct. To generate the plasmids TRpm(PE)-1.TRE and TRpm(PE)-4.TRE, a 548 bp EcoRI fragment from the Xenopus RXRγ with 0.7 volume of isopropanol and rinsed with cold 70% ethanol. DNAs were resuspended in 50 μl of TE buffer and used either for quantitative gene was cloned into the EcoRI site of the plasmids TRpm(P)-1.TRE and TRpm(P)-4.TRE and the clones with the insert in the same orientation analysis by slot hybridization as described or supercoiling assay as described below. were selected. This 548 bp EcoRI fragment contains no TRE site based on the sequence search. To generate the plasmid TRpm(PE)-TRE(E), the plasmid TRpm(PE)-1.TRE was partially digested with EcoRI and Micrococcal nuclease assay and supercoiling assay of chromatin disruption then ligated with the TRE duplex with EcoRI sites at both ends. The clone with a single TRE (5Ј AATTCAGGTCATCCTAGGTCAG 3Ј)
The MNase assay of chromatin structure was performed as described previously . Briefly, groups of 20-25 injected oocytes inserted into the EcoRI site between the CAT fragment and the inserted 548 bp fragment was selected. The plasmid TRpm(PE)-TRE(E)(B) was were collected after overnight incubation and homogenized in 300 ml of MNase buffer [10 mM HEPES, pH 8.0, 50 mM KCl, 5 mM MgCl 2 , a derivative of TRpm(PE)-TRE(E) with a single TRE (5Ј GATCGAGGT-CATCCTAGG TCAC 3Ј) inserted into the BglII site. The plasmid 3 mM CaCl 2 , 1 mM dithiothreitol (DTT), 0.1% NP-40 and 5% glycerol]. The extract was either divided into four fractions (60 μl each) and TRpm(PE)-TRE(E)(B)(B) was then generated by inserting a single TRE (5Ј GATCGAGGTCATCCTAGGTCAC 3Ј) into the BamHI site of digested with 10, 5, 2.5 and 1.25 U/ml of MNase (Worthington) respectively at room temperature for 20 min. MNase digestions were the plasmid TRpm(PE)-TRE(E)(B). The single-stranded DNAs were prepared from phagemids induced with helper phage VCS M13 as stopped by addition of 200 ml of 20 mM EGTA, 1% SDS. The reactions were treated with RNase A (100 μg/ml) at 37°C for 2 h, followed by described (Sambrook et al., 1989) . treatment with proteinase K (200 μg/ml) for 2-3 h at 55°C. After addition of 30 μl of 3 M NaOAC, pH 5.4, the reactions were phenol/ In vitro mRNA synthesis and microinjection of Xenopus oocytes chloroform extracted twice, precipitated with 0.7 volume of isopropanol and rinsed with cold 70% ethanol. DNAs were resolved by 1.5% agarose All the constructs for in vitro transcription were linearized with EcoRI, deproteinated with phenol/chloroform and ethanol precipitated. The gel, blotted to nylon membrane and probed with the indicated labeled DNA fragments. in vitro mRNA synthesis was carried out with an SP6 Message Machine Kit (Ambion) as described by the manufacturer. The preparation and
The supercoiling assay using chloroquine agarose gel was performed essentially as described (Clark and Wolffe, 1991) . To analyze DNA microinjection of Xenopus stage VI oocytes were essentially as described (Almouzni and Wolffe, 1993) . For transcription and chromatin disruption topology, 10 μl of each DNA samples were loaded onto a 1-1.2% agarose gel in 1ϫ TPE (40 mM Tris, 30 mM NaH 2 PO 4 and 10 mM analysis, a group of~20 oocytes were injected for each sample to minimize the variations of injection, and the mRNAs were usually EDTA) containing 90 μg/ml of freshly prepared chloroquine in both gel and running buffer. Under these gel conditions, the minichromosomes injected 2-3 h before injection of DNA. The DNA was injected (23 nl/oocyte) either as single-(100 ng/μl) or double-stranded DNA with nucleosome density from 180 to 270 bp/nucleosome can be resolved optimally into isomers with positive supercoiling due to the binding of (100 ng/μl) into the nuclei of the oocytes. The TR mRNAs were usually chloroquine to DNA, dependent on the differences in negative superinducible promoters and blocks activity of the retinoid acid receptor. coiling which resulted from the difference in nucleosome density. The New Biol., 1, 329-336. gels were run in the dark overnight at~3.5 V/cm. The gels were then Bresnick,E.H., Bustin,M., Marsaud,V., Richard-Foy,H. and Hager,G.L. washed with distilled water several times to remove chloroquine and (1992) The transcriptionally-active MMTV promoter is depleted of processed for DNA transfer to Nytran Plus membrane as described histone H1. Nucleic Acids Res., 20, 273-278. (Sambrook et al., 1989) . The DNA was probed with a random-primed Brownell,J.E., Zhou,J., Ranalli,T., Kobayashi,R., Edmondson,D.G., labeled DNA fragment from ϩ218 to ϩ314 of the TRβA promoter. Roth,S.Y. and Allis,C.D. (1996) E. and Weintraub,H. (1983) Temporal order of chromatin incubation and homogenized in 400 μl of MNase buffer (10 mM HEPES, structural changes associated with activation of the major chicken pH 8.0, 50 mM KCl, 5 mM MgCl 2 , 1 mM DTT, 0.1% NP-40 and 5% vitellogenin gene. Cell, 33, 65-76. glycerol). The extract was divided into four fractions (100 μl each) and Casanova,J. et al. (1994) Functional evidence for ligand-dependent digested with 80, 40, 20 and 10 U of DNase I (BRL) respectively at dissociation of thyroid hormone and retinoic acid receptors from an room temperature for 1 min. The reactions were stopped with addition inhibitory cellular factor. Mol. Cell. Biol., 14, 5756-5765. of 200 ml of 1% SDS and 20 mM EDTA. After the purification procedure Chakravarti,D., La Morte,V.J., Nelson,M.C., Nakajima,T., Schulman,I.G., as described for the MNase assay, each DNA sample was resuspended Juguilon,H., Montminy,M. and Evans,R.M. (1996) Role of CBP/p300 in 100 ml of TE buffer and treated again with RNase A (100 μg/ml) in nuclear receptor signaling. 
